Media Library
icon
-
ImagelockScience & Innovation / ImageT-Cell arrival at the Novartis manufacturing facilityA cancer patient's frozen T-Cells arrive at a Novartis facility to be reengineered.
-
ImagelockNovartis Social Business / ImageSMS for Life Training SessionSMS for Life training session teaching healthcare workers how to use text messaging to monitor stock levels of life-saving antimalarials. In Kenya, Machacos district, SMS for Life also includes patient surveillance data on the testing of malaria patients and the use of artemisinin-based combination therapies (ACTs).
-
ImagelockNovartis Social Business / ImageSMS for LifeSMS for Life is an innovative public-private partnership led by Novartis under the umbrella of the Roll Back Malaria Partnership. The program has been rolled out across Tanzania and pilots are taking place in Ghana and Kenya.
-
ImagelockScience & Innovation / ImagePatient's frozen T-CellsThe Frozen T-Cells of a cancer patient.
-
ImagelockScience & Innovation / ImageMode of Action of a CGRP Receptor BlockerMode of Action of a CGRP Receptor Blocker, calcitonin gene-related peptide (CGRP), CGRP receptor complex, CGRP receptor blocker targeting the receptor complex.
-
ImagelockScience & Innovation / ImageMalaria Researchers in Nairobi, KenyaMalaria researchers in Nairobi, Kenya, are working to stay one step ahead of the malaria parasite in order to provide innovative treatments to support elimination efforts.
-
ImagelockMalaria Initiative / ImageMalaria PreventionRural village, Lake Victoria region, Kenya: A teacher talks to school children about prevention and proper treatment of malaria. Simple tools like bed nets, effective medicines and indoor spraying have helped some African countries to reduce malaria deaths by 50% or more.
-
ImagelockMalaria Initiative / ImageMalaria Diagnostic TestRapid Diagnostic Tests (RDTs) assist in the diagnosis of malaria by detecting evidence of malaria parasites in human blood. They allow the testing of people who cannot access diagnosis based on microscopy.
-
ImagelockManufacturing / ImageFarmer Harvesting Artemisia AnnuaIn China, Novartis works with about 100,000 farmers who cultivate Artemisia annua, a crucial plant in the production of our antimalarial treatment.
-
ImagelockManufacturing / ImageArtemisinin ExtractionWe source our antimalarial treatment’s active pharmaceutical ingredients from China. Once the farming is done, the technical process begins. After the artemisinin has been extracted from the leaves, it is again dissolved in ethanol and processed for higher purity and quality. Here, a facility for the processing of artemisinin.
-
ImagelockImageArtemisinin-Combination Therapy (ACT)Deliveries of this child-friendly antimalarial hit the 300 million mark. This child-friendly ACT is the first WHO prequalified child-friendly artemisinin-combination therapy (ACT).
-
ImagelockManufacturing / ImageAntimalarial Raw MaterialAntimalarial raw material before it is made into pills.
Pagination
- ‹ Previous page
- 1
- …
- 19
- 20
- 21
- 22
- 23
- 24
- 25
- 26
- › Next page